# Effectiveness of Anthroposophic Speech Therapy in Patients With Asthma

> **NCT02501824** · PHASE2 · COMPLETED · sponsor: **University of Bern** · enrollment: 49 (actual)

## Conditions studied

- Asthma

## Interventions

- **OTHER:** anthroposophic therapeutic speech

## Key facts

- **NCT ID:** NCT02501824
- **Lead sponsor:** University of Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2014-08
- **Final completion:** 2014-11
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2015-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02501824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02501824, "Effectiveness of Anthroposophic Speech Therapy in Patients With Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02501824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*